PharmiWeb.com - Global Pharma News & Resources

Medical comms - Press Releases

Date Title Company
10-Nov-2021 New NHS collaboration supports optimisation of asthma management by reducing over-reliance on reliever inhalers and their carbon footprin AstraZeneca
21-Oct-2021 PharmiWeb.Jobs Welcomes Cros NT PharmiWeb.Jobs
21-Oct-2021 PharmiWeb.Jobs Welcomes PE Global PharmiWeb.Jobs
20-Oct-2021 Conference Chair Di Morris, AstraZeneca invites you to join SMi's 10th Annual Pharmaceutical Microbiology Conference SMi Group
18-Oct-2021 USING INNOVATIVE TECHNOLOGY TO ASSIST OPERATING THEATRES IN A COVID-19 ERA Hillrom
12-Oct-2021 Award-winning health agency 90TEN launches in the US 90TEN
12-Oct-2021 Targeted reduction of SARS-COV-2 viral load in the nose with photodisinfection may reduce severity of lower tract respiratory disease Ondine Biomedical
11-Oct-2021 Advanced kidney cancer patients in Scotland become amongst the first in world to access CABOMETYX®▼ (cabozantinib) in combination with OPDIVO® (nivolumab) via NHS Scotland, following SMC acceptance* Ipsen
05-Oct-2021 New Analysis Presented by Janssen at United European Gastroenterology Week (UEGW) Demonstrates Long-Term Safety Profile for STELARA® (ustekinumab) in Older Patients Across Approved Indications Janssen
23-Sep-2021 OPEN Health Acquires ARK OPEN Health
22-Sep-2021 Wave Healthcare Communications rebrands and announces new Board Wave Healthcare Communications
20-Sep-2021 STRIDE Data Show Translarna™ Delays Loss of Ambulation by More Than Five Years in Boys with Nonsense Mutation Duchenne Muscular Dystrophy PTC Therapeutics Inc.
20-Sep-2021 Omnicell to launch innovative new solution at this year’s Clinical Pharmacy Congress Omnicell
20-Sep-2021 Leading Microbiologists to meet at SMi’s 10th Annual Pharmaceutical Microbiology Conference SMi Group
15-Sep-2021 Within3 Reimagines Life Science Communications to Address Insight Gaps with Industry-first, Holistic Platform Within3
13-Sep-2021 AMGEN KRAS G12C INHIBITOR LUMYKRAS™▼ (SOTORASIB) RECEIVES CONDITIONAL MARKETING AUTHORISATION* BY MHRA FOR USE IN GREAT BRITAIN Amgen
17-Aug-2021 AXON appoints Colette Balaam as its new US Managing Partner AXON
12-Aug-2021 Biotium launches optimized solution for exosome detection by flow cytometry Biotium
11-Aug-2021 PONVORY®▼ (ponesimod), a Once Daily, Oral Therapy Authorised in Great Britain for the Treatment of Adults with Relapsing Forms of Multiple Sclerosis (RMS) with Active Disease Defined by Clinical or Imaging Features Janssen
10-Aug-2021 Galen Medical Nutrition Announces Scholarship Award Galen